BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 3,950.00
+235.00 (6.33%)
At close: Mar 12, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 19.46 billion as of March 13, 2026. Its market cap has decreased by -27.01% in one year.
Market Cap
19.46B
Enterprise Value
22.58B
Revenue
21.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,950.00
Market Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 19.46B, a decrease of -86.20%. That is a compound annual growth rate of -47.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 19.21B | -16.49% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 1.02T |
| DreamCIS | 126.57B |
| HLB bioStep | 103.22B |
| P&K Skin Research Center | 62.96B |
| WOOJUNG BIO | 60.67B |
| C&R Research | 46.78B |
| DT&CRO CO. | 39.50B |
| SLS BIO | 26.89B |